Shares of Australian specialty pharma firm Mayne Pharma Group (ASX: MYX) closed up 9.2% at A$3.68 today, after it released full-year fiscal 2023 financials, showing that reported revenues were A$183.6 million (US$118.5 million), up 17% on FY 2022.Reported gross profit was also up 17% at A$83.5 million, with net loss after tax coming in at A$317.4 million, compared with A$220.1 million the previous yearMayne says it has successfully refocused the company around core businesses with the exclusive US license to a portfolio of on-market women’s health products - Annovera (segesterone acetate/ethinyl estradiol), Imvexxy (segesterone acetate/ethinyl estradiol), Bijuva (estradiol and progesterone capsules) – acquired from TherapeuticsMD (Nasdaq: TXMD), as well as pre-natal vitamins. Also contributing was the sale of Metrics Contract Services (MCS) and US Retail GenericsContinued revenue growth of Branded Products was noted, at A$61.9 million in FY 2023 versus A$10.6 million FY 2022 (up 484%) and International A$64.7 million, up 19%. Portfolio products rebounded in the second half of the year, with second half 20223 revenue up 313% from first half 2023.
- Forums
- ASX - By Stock
- Mayne Pharma sees strong sales growth in FY 2023
Shares of Australian specialty pharma firm Mayne Pharma Group...
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.93 |
Change
0.030(0.61%) |
Mkt cap ! $419.4M |
Open | High | Low | Value | Volume |
$4.92 | $4.94 | $4.81 | $766.3K | 156.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 110 | $4.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.94 | 993 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 110 | 4.910 |
1 | 110 | 4.900 |
1 | 110 | 4.890 |
1 | 110 | 4.880 |
3 | 1103 | 4.870 |
Price($) | Vol. | No. |
---|---|---|
4.940 | 993 | 1 |
4.950 | 1103 | 2 |
4.960 | 1103 | 2 |
4.970 | 110 | 1 |
4.980 | 110 | 1 |
Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
$4.91 |
  |
Change
0.030 ( 0.29 %) |
|||
Open | High | Low | Volume | ||
$4.92 | $4.94 | $4.82 | 85313 | ||
Last updated 15.59pm 05/06/2024 ? |
Featured News
MYX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online